Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson ’s disease
Parkinson ’s disease (PD) is a common and costly progressive neurodegenerative disease of unclear etiology. A disease-modifying approach that can directly stop or slow its progression remains a major unmet need...
Source: Journal of Neuroinflammation - Category: Neurology Authors: Jae-Bong Kim, Yujeong Kim, Soo-Jeong Kim, Tae ‑Young Ha, Dong-Kyu Kim, Dong Won Kim, Minyoung So, Seung Ho Kim, Hyun Goo Woo, Dukyong Yoon and Sang Myun Park Tags: Research Source Type: research
More News: Allegra | Brain | Fexofenadine | Health Insurance | Insurance | Neurology | Parkinson's Disease